Abstract
e12555Background: Oncotype DX is a commercial diagnostic test used to predict the likely benefit from chemotherapy in ER+ HER2- node- breast cancer. Patients with multiple, synchronous ipsilateral ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
